269 related articles for article (PubMed ID: 31412792)
1. CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors.
Fankhauser CD; Roth L; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Moch H; Bode PK; Beyer J; Hermanns T
BMC Cancer; 2019 Aug; 19(1):802. PubMed ID: 31412792
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
Zhou Y; Rothrock A; Murugan P; Li F; Bu L
Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
[TBL] [Abstract][Full Text] [Related]
3. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
4. Cell-to-cell variation of chromosomal number in the adult testicular germ cell tumors: a comparison of chromosomal instability among histological components and its putative role in tumor progression.
Miyai K; Ito K; Nakanishi K; Tsuda H
Virchows Arch; 2019 Jun; 474(6):711-720. PubMed ID: 30877382
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents.
Gilbert DC; Chandler I; McIntyre A; Goddard NC; Gabe R; Huddart RA; Shipley J
J Pathol; 2009 Jan; 217(1):94-102. PubMed ID: 18839394
[TBL] [Abstract][Full Text] [Related]
6. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract][Full Text] [Related]
8. Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.
Gilbert DC; Al-Saadi R; Thway K; Chandler I; Berney D; Gabe R; Stenning SP; Sweet J; Huddart R; Shipley JM
Clin Cancer Res; 2016 Mar; 22(5):1265-73. PubMed ID: 26453693
[TBL] [Abstract][Full Text] [Related]
9. Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma.
Miyai K; Ito K; Nakanishi K; Tsuda H
Hum Pathol; 2019 Feb; 84():71-80. PubMed ID: 30266250
[TBL] [Abstract][Full Text] [Related]
10. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract][Full Text] [Related]
11. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Characterization of Bilateral Testicular Germ Cell Tumors With Immunohistochemical Evaluation of Mismatch Repair and
Al-Obaidy KI; Trevino KE; Idrees MT
Int J Surg Pathol; 2019 Sep; 27(6):619-623. PubMed ID: 30983459
[TBL] [Abstract][Full Text] [Related]
13. Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors.
Miyai K; Yonekura Y; Ito K; Matsukuma S; Tsuda H
Virchows Arch; 2021 Dec; 479(6):1177-1186. PubMed ID: 34347114
[TBL] [Abstract][Full Text] [Related]
14. What Is the Significance of Rete Testis Invasion by Malign Germ Cell Tumor and Does Hilum Predict Metastasis?
Ediz C; Ihvan A
Urol Int; 2019; 103(1):49-54. PubMed ID: 31203276
[TBL] [Abstract][Full Text] [Related]
15. Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.
Masiuk M; Lewandowska M; Teresinski L; Dobak E; Urasinska E
Folia Histochem Cytobiol; 2019; 57(3):139-145. PubMed ID: 31513277
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
[TBL] [Abstract][Full Text] [Related]
17. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract][Full Text] [Related]
18. Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.
Lewin J; Soltan Ghoraie L; Bedard PL; Hamilton RJ; Chung P; Moore M; Jewett MAS; Anson-Cartwright L; Virtanen C; Winegarden N; Tsao J; Warde P; Sweet J; Haibe-Kains B; Hansen AR
BJU Int; 2018 Nov; 122(5):814-822. PubMed ID: 29726090
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
20. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]